Berkshire Hathaway Rose While Every Major Chip Stock Fell Monday

Berkshire Hathaway’s B shares rose ~1.3% to ~$502 Monday as the chip complex sold off (Nvidia -2%, AMD -3%, Broadcom -2%, Intel -3%, Micron -5%). Berkshire reported Q2 operating earnings up 16% Y/Y to about $13B, supported by gains in manufacturing/services (+24%), Berkshire Hathaway Energy (+27%), and BNSF (+$1.6B, +6%). The company also held about $360B in cash and Treasury bills and repurchased about $4.5B of shares in Q2, helping underpin demand for its “AI-independent” earnings profile.

Analysis

This looks less like a Berkshire-specific rerating than a factor rotation out of long-duration AI capex and into “self-funding” balance sheets. The market is paying up for cash flow that does not depend on hyperscaler spend staying at peak intensity, which is why the relative winner is the whole cash-rich, non-cyclically funded cohort rather than BRK.B alone. The flip side is that the most levered semiconductor suppliers — especially names with stretched expectations and high operating leverage — are the first place where even a modest pause in AI ordering can compress multiples quickly.

Near term, the key catalyst is not Berkshire’s print but the chip earnings/guidance window over the next 48 hours. If management commentary confirms capex digestion rather than acceleration, this defensive tape can extend for 1-3 months as PMs de-gross from crowded AI winners into low-beta compounders. If the guidance comes in clean and buyback/inference demand remains intact, the move likely mean-reverts fast because the market has already priced in a lot of “AI spend fatigue” over just one week.

The contrarian point: Berkshire is not cheap on operating earnings, so this is not a classic quality-at-any-price refuge. In a true risk-off, BRK.B still carries equity beta through its portfolio and cyclical exposure through freight/insurance, while semis can rebound violently on even slight positive revisions. The better expression is relative, not absolute: long the defensive cash compounder against the most consensus AI beta, with a tight trigger if semis reclaim lost ground after earnings.

Key Decisions for Investors

• Long BRK.B / short SOXX for 2-6 weeks as a rotation trade; target relative outperformance if AI capex commentary softens into earnings, but stop if SOXX reclaims the prior week’s drawdown on guidance beats.
• If you want single-name exposure, pair long BRK.B against short NVDA or AVGO into Wednesday’s print; the risk/reward is favorable only for a tactical hedge, not a multi-month structural short.
• Watch MU and AMD as the highest beta read-throughs on demand digestion; a weak guide from either would confirm a 1-3 month de-rating cycle across the group.
• Take profits on any defensive rally if BRK.B approaches its recent highs while real yields stabilize; at that point the market is likely just paying up for safety, not revising fundamentals.